-
Symbol
-
URGN on Nasdaq
-
Investment type
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Latest Disclosed Shares Owned
-
838,615 shares
-
Security Ownership %
-
1.8%
Monograph Capital Partners I, L.P. ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)
09 Jun 2025 - Monograph Capital Partners I, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 838,615 shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).
This represents 1.8% ownership of the company.
This is the first filing by Monograph Capital Holdings Advisors, LLC disclosing ownership of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN).